Recent progress in neuronal intranuclear inclusion disease: a review of the literature.
Biopsy
Dementia
Diffusion-weighted-imaging
Neuronal intranuclear inclusion disease
Ubiquitin
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
13
08
2019
accepted:
10
12
2019
pubmed:
4
1
2020
medline:
9
2
2021
entrez:
4
1
2020
Statut:
ppublish
Résumé
To summarize the current understanding of neuronal intranuclear inclusion disease (NIID) and improve the understanding of the physician about this condition. We searched PubMed with keywords related to NIID and selected publications which seemed appropriate. We analyzed its clinical features, pathogenesis, evaluation methods, treatment options, and research prospectives. NIID is a degenerative condition which can affect multiple organ systems especially central nervous system. Its clinical features greatly vary, and making the exact diagnosis is often difficult. There are several genes which have been associated with this disorder. Some specific signs on diffusion-weighted-imaging (DWI) sequence of magnetic resonance (MR) imaging are characteristics to NIID. Intranuclear inclusions have been found in various nonneural cells of the body; therefore, the term systemic intranuclear inclusion disease is, perhaps, better suited to explain this disorder. There are several disorders which need to be ruled out before making the diagnosis, and neuroimaging and biopsy analysis should be combined to support the diagnosis.
Identifiants
pubmed: 31897935
doi: 10.1007/s10072-019-04195-6
pii: 10.1007/s10072-019-04195-6
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM